Apolipoprotein-B, Low-Density Lipoprotein Cholesterol, and the Long-Term Risk of Coronary Heart Disease in Men

2006 ◽  
Vol 97 (7) ◽  
pp. 997-1001 ◽  
Author(s):  
Annie C. St-Pierre ◽  
Bernard Cantin ◽  
Gilles R. Dagenais ◽  
Jean-Pierre Després ◽  
Benoît Lamarche
2012 ◽  
Vol 15 (3) ◽  
pp. 292-308 ◽  
Author(s):  
Christopher C. Imes ◽  
Melissa A. Austin

Coronary heart disease (CHD) affects 17 million people in the United States and accounts for over a million hospital stays each year. Technological advances, especially in genetics and genomics, have changed our understanding of the risk factors for developing CHD. The purpose of this article is to review low-density lipoprotein cholesterol (LDL-C), apolipoprotein B (apo B), and risk of CHD. The article focuses on five topics: (1) a description of lipoprotein classes, normal lipoprotein metabolism, and the biological mechanism of atherosclerosis; (2) a review of selected epidemiologic and clinical trial studies examining the associations between elevated LDL-C and apo B with CHD; (3) a brief review of the familial forms of hyperlipidemia; (4) a description of variants in genes that have been associated with higher LDL-C levels in candidate gene studies and genome-wide association studies (GWAS); and (5) nursing implications, including a discussion on how genetic tests are evaluated and the current clinical utility and validity of genetic tests for CHD.


2003 ◽  
Vol 91 (9) ◽  
pp. 1134-1136 ◽  
Author(s):  
Christopher C. Case ◽  
Terry A. Jacobson ◽  
Susan Roberts ◽  
Ann Buckley ◽  
Kathleen M. Murtaugh ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document